Podcast: Fighting blindness with CRISPR. Ophthalmologist in groundbreaking study explains how gene editing could treat a once-incurable disease

eyes
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Congenital eye disorders can rob children of their eyesight at a young age and severely diminish their quality of life as they grow up. Over 60 percent of cases of blindness among infants are caused by such inherited conditions, and for many years, there was little modern medicine could do. But that’s beginning to change as the gene-editing revolution advances, enabling physicians to replace and modify the damaged DNA responsible for these disorders.

In early March, researchers for the first time ever treated a patient born with Leber congenital amaurosis (LCA), a rare genetic condition that causes severe visual impairment, using CRISPR. To administer the therapy, scientists inject a harmless virus carrying the instructions to produce CRISPR-Cas9 directly into the patient’s eye, where it is expected to edit out a mutation in the CEP290 gene responsible for the most common subtype of LCA known as Type 10.

Although a gene therapy for a different LCA subtype has been approved by the FDA, the recent effort to correct the mutation in CEP290, if successful, will offer the first treatment for LCA10. The gene-editing procedure also marks the first attempt to edit DNA inside a living patient, signaling a significant step forward in biomedicine.

Related article:  BRCA mutations can be deadly or harmless. Now CRISPR can tell the difference

The groundbreaking treatment raises all sorts of questions, most pressing among them: is the procedure safe, and will it really restore sight? On this episode of Science Facts and Fallacies, geneticist Kevin Folta and GLP editor Cameron English sit down with Dr. Mark Pennesi, Associate Professor of Ophthalmology at Oregon Health and Science University, to get some answers. Pennesi is one of several specialists conducting the BRILLIANCE clinical trial to evaluate the novel CRISPR therapy for LCA10.

Mark Pennesi is a professor of ophthalmology at Oregon Health and Science University who specializes in degenerative retinal disorders. He completed a combined M.D./Ph.D. at Baylor College of Medicine. Visit his website

Kevin M. Folta is a professor in the Horticultural Sciences Department at the University of Florida. Follow Professor Folta on Twitter @kevinfolta

Cameron J. English is the GLP’s senior agricultural genetics and special projects editor. BIO. Follow him on Twitter @camjenglish

 

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
sperm swim

Video: Sperm are ‘spinners not swimmers’—because they are lopsided

Research by fertility scientists in the UK and Mexico challenges the accepted view of how sperm “swim”, suggesting that it ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
breastfeeding bed x facebook x

Infographic: We know breastfeeding helps children. Now we know it helps mothers too

When a woman becomes pregnant, her risk of type 2 diabetes increases for the rest of her life, perhaps because ...
biotechnology worker x

Can GMOs rescue threatened plants and crops?

Some scientists and ecologists argue that humans are in the midst of an "extinction crisis" — the sixth wave of ...
food globe x

Are GMOs necessary to feed the world?

Experts estimate that agricultural production needs to roughly double in the coming decades. How can that be achieved? ...
eating gmo corn on the cob x

Are GMOs safe?

In 2015, 15 scientists and activists issued a statement, "No Scientific consensus on GMO safety," in the journal Environmental Sciences ...
Screen Shot at PM

Charles Benbrook: Agricultural economist and consultant for the organic industry and anti-biotechnology advocacy groups

Independent scientists rip Benbrook's co-authored commentary in New England Journal calling for reassessment of dangers of all GMO crops and herbicides ...
Screen Shot at PM

ETC Group: ‘Extreme’ biotechnology critic campaigns against synthetic biology and other forms of ‘extreme genetic engineering’

The ETC Group is an international environmental non-governmental organization (NGO) based in Canada whose stated purpose is to monitor "the impact of emerging technologies and ...
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend